6-OHDA |
6-hydroxydopamine |
acetyl-CoA |
Acetyl form of coenzyme A |
ADOA |
Autosomal dominant optic atrophy |
Cas9 |
CRISPR-associated protein 9 |
CMT2 |
Charcot-Marie-Tooth Type 2 |
CNS |
Central nervous system |
COA |
COX assembly factor |
CoQ |
Coenzyme Q |
COX |
Cytochrome c oxidase |
CRISPR |
Clustered regularly interspaced short palindromic repeats |
Cys |
Cysteine |
cyt c
|
cytochrome c
|
DNP |
2-4 dinitrophenol |
DOA |
Dominant optic atrophy |
DS |
Dravet syndrome |
EC |
Enzyme complexes |
ENU |
N-ethyl-N-nitrosourea |
Hcy |
Homocysteine |
MADD |
Multiple acyl-CoA dehydrogenase deficiency |
MCS |
Mitochondrial carriers |
MO |
Morpholino oligonucleotide |
MPP+
|
1-methyl-4-phenylpyridinium |
MPTP |
1-methylmethyl-4-phenylphenyl-1,2,3,6-tetrahydropyridinetetrahydropyridine |
mRNA |
Messenger RNA |
mtDNA |
Mitochondrial DNA |
nDNA |
Nuclear DNA |
NGS |
Next-generation sequencing |
OxPhos |
Oxidative phosphorylation |
PBA |
4-phenylbutyrate |
PCH |
Pontocerebellar hypoplasia |
PD |
Parkinson’s disease |
PDHC |
Pyruvate dehydrogenase complex |
pLL |
Posterior lateral line |
PNS |
Peripheral nervous system |
ROS |
Reactive oxygen species |
rRNA |
Ribosomal RNA |
TALEN |
Transcription activator-like effector |
tRNA |
Transfer RNA |